Newsletter Subscribe
Enter your email address below and subscribe to our newsletter
Treatment
Share your love
Oasis Medical Launches New Tapered Plug for DED Treatment
Oasis Medical has recently unveiled its latest product, the SOFT PLUG Extended Duration 180-T Tapered Plug, which is engineered to aid individuals suffering from dry eye syndrome and related ocular surface diseases. The new tapered plugs are designed for ease…
Haag-Streit Unveils Retinopathy of Prematurity Simulator
In a significant development aimed at enhancing the training of ophthalmologists, Haag-Streit has unveiled the Eyesi Indirect Ophthalmoscope ROP Simulator. This novel simulator is specifically designed for the training of retinal examinations on preterm infants and the classification of retinopathy…
Lenz Therapeutics Reports Study Success for Presbyopia
Lenz Therapeutics announced positive topline results from its Phase 3 CLARITY study, evaluating two investigational formulations, LNZ100 and LNZ101, aimed at treating presbyopia. The study’s findings showcase the effectiveness and safety of these formulations, particularly highlighting LNZ100 (1.75% aceclidine) for…
Zeiss Completes Acquisition of DORC
In a significant move for the ophthalmology sector, Carl Zeiss Meditec announced the successful acquisition of 100% shares of the Dutch Ophthalmic Research Center (DORC), a transaction that has now received all necessary regulatory approvals. This acquisition from Eurazeo SE,…
Qlaris Bio Begins Phase 2 Trials of QLS-111 for Eye Conditions
Qlaris Bio has commenced two critical Phase 2 trials in the United States for its innovative intraocular pressure (IOP)-lowering product, QLS‑111. These masked, randomized clinical trials are designed to investigate the efficacy of QLS‑111 in patients suffering from ocular hypertension…
West Point and Verséa Sign Supply Deal for Ocular Products
In a significant move for ocular health and treatment, West Point Optical Group (WPOG), the operator of 86 Pearle Vision stores, has joined forces with Verséa Ophthalmics in an exclusive partnership supply agreement. Under this new deal, Verséa Ophthalmics is…
Pantheon Vision Gets Another $1.8M for Corneal Implants
Pantheon Vision, a pioneering medical device company in the pre-clinical stage focused on developing bioengineered corneal implants, has secured an additional $1.8 million in funding. This recent financial boost is part of a second tranche from KeraLink International (KLI), following…
ViaLase Raises $40M for Glaucoma Laser Tech
ViaLase has successfully completed a Series C financing round, raising a substantial $40 million. This funding boost is set to accelerate the development, regulatory approval, and commercialization efforts of the ViaLase Laser, a pioneering medical device developed for the treatment…
Viatris Launches RYZUMVI™ 0.75% in the United States
Viatris Inc. announced the commercial launch of RYZUMVI™ (phentolamine ophthalmic solution) 0.75% in the United States. This treatment is the only FDA-approved eye drop available in the U.S. market designed to reverse pharmacologically-induced mydriasis, commonly caused by adrenergic agonists like…
GRF Releases Audiobook for the Visually Impaired
The Glaucoma Research Foundation (GRF) has recently released a 48-minute audiobook version of their comprehensive 40-page educational guide, “Understanding and Living with Glaucoma.” This project aims to extend the reach of their essential information to those affected by glaucoma, especially…